Results 61 to 70 of about 12,753 (177)

Recessive mutation in GALNT3 causes hyperphosphatemic familial tumoral calcinosis associated with chronic recurrent multifocal osteomyelitis

The Turkish Journal of Pediatrics, 2019
Hyperphosphatemic familial tumoral calcinosis is a rare autosomal recessive disorder that is characterized by persistent hyperphosphatemia and extra-articular calcifications.
Jumana Albaramki, Haitham Dmour, Mohammad Shboul, Carine Bonnard, Byrappa Venkatesh, Rasha Odeh   +5 more
doaj   +1 more source

Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients

Journal of the Formosan Medical Association, 2010
Sevelamer hydrochloride is a recently developed phosphate binder, which is a quaternary amine anion exchanger without calcium or aluminum. Sevelamer is effective in controlling hyperphosphatemia without increasing the calcium load in chronic hemodialysis
Yu-Feng Lin, Yung-Ming Chen, Kuan-Yu Hung, Tzong-Shinn Chu, Wei-Chih Kan, Chih-Yuan Huang, Shuei-Liong Lin, Tze-Wah Kao, Jenq-Wen Huang, Wen-Chih Chiang, Chung-Jen Yen, Tun-Jun Tsai, Kwan-Dun Wu, Ming-Shiou Wu   +13 more
doaj   +1 more source

Hypercalciuria in Postmenopausal Osteoporosis

Türk Osteoporoz Dergisi, 2004
Women aged between 35 to 75, termed as postmenopausal at least for one year, not smoking and not drinking alcohol, not using any medicine related with menopause and osteoporosis made up our patient and control groups.
Ayfer Kanberoğlu, Şule Tütün, Hale Aral, Güvenç Güvenen   +3 more
doaj  

NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD

Kidney International Reports, 2018
Serum phosphate levels are insufficiently controlled in many patients with end-stage renal disease (ESRD), and novel therapeutic strategies are needed. Blocking intestinal phosphate absorption mediated by sodium-dependent phosphate co-transporter type 2b
Tobias E. Larsson, Chisato Kameoka, Ikumi Nakajo, Yuta Taniuchi, Satoshi Yoshida, Tadao Akizawa, Ronald A. Smulders   +6 more
doaj   +1 more source

Hyperphosphatemia in a Patient with Candida Sepsis [PDF]

Clinical Chemistry, 2014
A 56-year-old man with a history of intravenous drug use and multiple infectious complications developed candida fungemia, which was initially treated with fluconazole and then liposomal amphotericin. At admission, he had normal calcium, phosphate, and magnesium but developed persistent hyperphosphatemia (phosphotungstate on Beckman DCxI) with values ...
openaire   +2 more sources

Urinary Fractional Excretion of Phosphorus in Dogs with Spontaneous Chronic Kidney Disease

Veterinary Sciences, 2017
The increase of urinary fractional excretion of phosphorus (uFEP) may indicate phosphorus retention before the onset of hyperphosphatemia in the early stages of chronic kidney disease (CKD).
Cínthia Ribas Martorelli, Márcia Mery Kogika, Fernanda Chicharo Chacar, Douglas Segalla Caragelasco, Ana Carolina Brandão de Campos Fonseca Pinto, Carla Aparecida Batista Lorigados, Lúcia Conceição Andrade   +6 more
doaj   +1 more source

Dietary Management of Hyperphosphatemia [PDF]

American Journal of Kidney Diseases, 2018
Shivam, Joshi, Vishnu, Potluri, Siddharth, Shah   +2 more
openaire   +2 more sources

Safety and Phosphate‐Binding Capacity of Oxylanthanum Carbonate in Healthy Volunteers

Clinical and Translational Science
Despite the widespread use of currently available serum phosphate management options, elevated serum phosphate is common in patients with end‐stage kidney disease on dialysis.
Pablo E. Pergola, Melanie S. Joy, Armando Garsd, Steve J. Hasal, Atul Khare, Guru Reddy, Pramod Gupta, William F. Finn   +7 more
doaj   +1 more source

Hyperphosphatemia

Saudi Medical Journal, 2015
Hyperphosphatemia is a major cause of morbidity and mortality in patients with chronic kidney disease. The association between hyperphosphatemia and increased risk of death from cardiovascular disease/vascular calcification has been well established for a long time.
openaire   +2 more sources

The U-shaped association between initial serum phosphate level and mortality of traumatic brain injury patients

Frontiers in Neurology
BackgroundPhosphate disorders, including hypophosphatemia and hyperphosphatemia, influence the prognosis of patients. We designed this study to explore the relationship between serum phosphate levels and mortality in traumatic brain injury (TBI) patients.
Ruoran Wang, Xin Yang, Jianguo Xu, Min He   +3 more
doaj   +1 more source